Skip to main content
Article
The CAR-HEMATOTOX Risk-Stratifies Patients for Severe Infections and Disease Progression after CD19 CAR-T in R/R LBCL.
Journal for Immunotherapy of Cancer (2022)
  • Ariel Perez Perez, Baptist Health South Florida
  • Additional authors and institutional affiliations
Publication Date
May, 2022
Citation Information
Ariel Perez Perez and Additional authors and institutional affiliations. "The CAR-HEMATOTOX Risk-Stratifies Patients for Severe Infections and Disease Progression after CD19 CAR-T in R/R LBCL." Journal for Immunotherapy of Cancer (2022)
Available at: http://works.bepress.com/ariel-perezperez/18/